ALIVUS LIFE SCIENCES
Back to Balance Sheet
|
ALIVUS LIFE SCIENCES Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹466 Cr | ₹757 Cr | ₹67 Cr | ₹33 Cr | ₹23 Cr |
What is the latest Total Non-Current Liabilities ratio of ALIVUS LIFE SCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹466 Cr |
| Mar2024 | ₹757 Cr |
| Mar2023 | ₹67 Cr |
| Mar2022 | ₹33 Cr |
| Mar2021 | ₹23 Cr |
How is Total Non-Current Liabilities of ALIVUS LIFE SCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹466 Cr | -38.43 | |
| Mar2024 | ₹757 Cr | 1,023.14 | |
| Mar2023 | ₹67 Cr | 106.11 | |
| Mar2022 | ₹33 Cr | 42.87 | |
| Mar2021 | ₹23 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹11,203.7 Cr | 0.7% | -5% | -9.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | 0.7% |
-5% |
-9.6% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses